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collect with G-CSF and chemotherapy are under consideration as
well as the utilization of the drug, AMD-3100 (AnorMED, Inc).422
EFFICACY OF MOUTH RINSES DURING CYTARABINE INFUSION IN
PREVENTING ORAL MUCOSITIS IN THE RECIPIENTS OF ALLOGENEIC
HEMATOPOIETIC STEM CELL TRANSPLANTATION CONDITIONED BY
HIGH-DOSE CYTARABINE AND TOTAL BODY IRRRADIATION
Hasegawa, K.1, Okabe, A.1, Kawada, Y.1, Tsujimura, N.1, Yashima, T.1,
Kobayashi, N.1, Kondo, S.1, Mori, T.2, Okamoto, S.2. 1Keio University
Hospital, Tokyo, Japan; 2Keio Univeristy School of Medicine, Tokyo,
Japan.
Background: Oral mucositis is one of the serious and frequent
conditioning-associated toxicities of allogeneic hematopoietic
stem cell transplantation (HSCT).We recently reported that cytar-
abine is excreted in the saliva after its high-dose administration, and
the cytarabine exreted in the saliva could play some role in causing
oral mucositis after HSCT (Anti-Cancer Drugs 2006; 17; 597).
Based on this finding, the efficacy of mouth rinses during cytarabine
infusion in preventing oral mucositis was prospectively evaluated in
allogeneic HSCT recipients treated with high-dose cytarabine.
Patients andMethods: Fifteen patients who underwent allogeneic
HSCT at Keio University Hospital between November 2006 and
June 2007 after being conditioned with TBI and high-dose cytara-
bine as described below were evaluated. Following TBI (12 Gy), cy-
tarabine at a dose of 3 g/m2 was administered intravenously over 2
hours every 12 hours for 4 consecutive days. Stem cells were bone
marrow from related (n 5 4) or unrelated (n 5 11) donor. Patients
were instructed to rinse their mouth with cold water every 10 min-
utes for 2 hours during cytarabine infusion and for additional 1 hour
after completion of cyrabine infusion. The grades of oral mucositits
were evaluated using National Cancer Institute Common Toxicity
Criteria (NCI-CTC) every day from the day of the first dose of cy-
tarabine to day 28 after HSCT and the maximum grade of each pa-
tient was considered as his or her grade.Results:The grades of oral
mucositis in 15 patients who performedmouth rinses wereGrade 0–
1 in 9 patients, and Grade 2 in 6 patients (40%): no patients devel-
opedGrade 3 oral mucositis. The grades of oral mucositis in control
patients receiving the same conditioning without mouth rinses (n5
35) were Grade 0–1 in 7, Grade 2 in 19 patients (54.3%), and Grade
3 in 9 patients (25.7%). Incidence of Grades 2–3 and Grade 3 oral
mucositis were significantly lower in patients who performedmouth
rinses as compared with control patients (40% vs. 80%; P5 0.009,
0% vs. 25.7%; P 5 0.02, respectively). Conclusion: Our findings
suggest that mouth rinses during cytarabine infusion could reduce
the incidence of oral mucositis caused by high-dose cytarabine. Al-
though this efficacy of mouth rinses is considered primarily due to
the removal of excreted cytarabine in the saliva, synergistic or addi-
tive effect of oral cryotherapy might contribute to the efficacy since
cold water was used for mouth rinses.423
LOWER LEGMUSCLE STRENGTH AND FATIGUE IN PATIENTS RECEIVING
HEMATOPOIETIC CELL TRANSPLANTATION UP TO TWOMONTHS AFTER
HOSPITAL DISCHARGE
Tonosaki, A. St Luke’s College of Nursing, Chuo-ku, Tokyo, Japan.
Purpose: To identify the factors relating to fatigue receiving
BMT up to two months after hospital discharge in order to provid
nursing care for early recovery.Method:The study was conducted
from November 2002 to November 2006. Sixty-six participants
were recruited at ResearchHospital of The Institute ofMedical Sci-
ence at Tokyo, Japan. Eligibility criteria for participation in the
study were: (1) more than 18 years old (2) scheduled for first time
transplantation (3) no uncontrolled hypertension, uncontrolled
pain, or unstable bone lesion. Approval was obtained from the ethics
committees at the hospital and authors’ belonging institution. Par-
ticipants were measured leg muscle strength (knee extension, ankle
plantar flexion, dorsiflexion strengths, and cross-sectional area ofthe thigh), State-Trait Anxiety Inventory (STAI-S) and Cancer Fa-
tigue Scale for Japanese (CFS). The measurement was performed
for 3 times, those were before entering the laminar air flow (LAF)
room, before hospital discharge and about two months after dis-
charge. In addition, steps per day was recorded by pedometer and
food intake data was collected from medical records. Multiple re-
gression analysis using stepwise regression (SPSS ver.14.0) was con-
ducted for factors relating to fatigue score after discharge. Result:
Twenty-five subjects who completed all 3 time-measurements
were examined. Twenty-two subjects had received cord blood
transplantation and three subjects had received BMT. The average
steps per day were 3304.8 (SD 1846.10) at twomonths after hospital
discharge. Post-transplantation days required to intake at least half
of meal portions (hereafter referred to as food intake recovery) was
91.1 (SD 42.21) days, and a significant correlation was noted be-
tween STAI-S and CFS for all points. Multiple regression analysis
demonstrated positive paths from food intake recovery (b5 .359;
P 5 .049) and average steps per day after discharge (b5 .357; P 5
.056) and negative path from ankle plantar flexion strength before
discharge (b5 -.435; P5 .020) to fatigue scores at two month after
discharge. Steps per day at after discharge was significantly corre-
lated with Cognitive domain in CFS after discharge (r 5 .566,
P 5 .003, n 5 25) Discussion: Results indicated that patients
may suffer from weakness during walking due to reduced muscle
strength in the ankle joints after transplantation. So preventive resis-
tance training should be started after early stage transplantation.424
PEDIATRIC PHERESIS LEG SPLINT IMMOBILIZATION TO INCREASE EFFI-
CIENCY OF STEM CELL COLLECTION AND CONTROL FEMORAL PHERE-
SIS CATHETER MALFUNCTIONS
Yocco, M., Healy, D., Barnes, Y., Chadakhtzian, A., Heidotten, A.,
Shenoy, S., Hayashi, R. St. Louis Chidren’s Hospital, St. Louis, MO.
Problem:Femoral pheresis cathetermafunction has been a recur-
ring problem in the infant to three year old population at St. Louis
Childrens Hospital. The very young pediatric patient would en-
counter problems with pheresis due to their inability to maintain
leg alignment during the procedure, resulting in kinked and ob-
structed femoral pheresis lines. The pheresis line malfunctions of-
ten require second pheresis line placement, increase cost and
length of hospital stay, increase sedation and sometimes result in
missing peak collection dates due to the line malfunction. Plan:
Prior to pheresis the patient was measured and a soft pheresis leg
splint was designed to immobilize the patients leg in which the phe-
resis catheter would be placed. The pheresis leg splint was placed on
the patient in the recovery room and remained in place until the
pheresis process was completed. Evaluation: The evaluation of
our experience with a active infant who underwent pheresis, while
utilizing the pheresis leg splint, was very positive. The patient re-
quired three days of pheresis to meet the stem cell goal and the
splint remained intact through out the process. The pheresis leg
splint maintained the proper alignment and pheresis was performed
without any catheter malfunctions. In the past it has been our expe-
rience that three days of pheresis in this age group would involve
multiple line complications and those issues made for a frustrating
pheresis experience for patient, family and healthcare providers.
Future Plans: A research study will be conducted with patients
from infant to three years of age using the pheresis leg splint and ret-
rospectively comparing a similar population of patients and their
pheresis outcomes. The catheter malfunction rate, cost and length
of hospital stay, sedation requirements and pheresis cell count will
be analyzed to determine the relevance of the pheresis leg splint
in the very young noncompliant pediatric patient population.425
IMPLEMENTATION OF A DEVELOPMENTAL FORM TO IMPROVE COM-
MUNICATION AND FOSTER CLINICAL DEVELOPMENT FOR THE BLOOD
AND MARROW TRANSPLANT NURSE AFTER THE ORIENTATION PERIOD
ENDS
Ellison, L.M. Stanford Hosptial and Clinics, Stanford, CA.
